Nasal Sample Articles & Analysis: Older
-
Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™ SARS-CoV-2 Rapid Antigen Test. The CoviDx test gives qualified healthcare providers qualitative, easy-to-interpret results within 15-20 minutes in cases of suspected COVID-19 and when performing serial ...
-
Anavasi Diagnostics Announces FDA EUA Submission for Its COVID-19 Test
Anavasi Diagnostics announced today that it has submitted the required EUA Clinical Study Data for the AscencioDx®, the molecular diagnostic platform for the detection of RNA indicative of the presence of the SARS-CoV-2/COVID-19 virus, to the Food and Drug Administration (FDA). Anavasi is a medical technology company focused on the development of novel molecular diagnostic testing. It uses a ...
-
Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance
Since the emergence of SARS-CoV-2, public health laboratories and researchers have been developing surveillance methods using wastewater to control the spread of COVID-19. The effort has helped identify asymptomatic carriers on college campuses to monitor regional spread among communities and capture emerging mutations ahead of potential future outbreaks. To support these efforts, Thermo Fisher ...
-
New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability
Anavasi Diagnostics, a medical technology company focused on the development of novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology, today announced it has been awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative. The funding will accelerate the launch and broad market ...
-
iXensor’s newly launched product, PixoTest® COVID -19 Antigen Self-Test Kit, could detect the COVID -19 major strain Omicron BA.5, combining the self-reporting function of PixoHealth App, leading to a safe, secured, and protected social new normal
iXensor, the pioneer of mobile health, today announced its “PixoTest® COVID -19 Antigen Self-Test Kit” has been granted by Taiwan FDA for EUA, in response to the recent peak of the epidemic and the new quarantine mandate of 0+7 taking effect on Oct 13th, Taiwan will officially enter the era of “self-initiated epidemic prevention”. The latest study of variant ...
By iXensor
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you